Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/02/031486
CTRI/2021/02/031486
Not yet recruiting
未知

EVALUATION AND COMPARISON OF EFFICACY OF POLYHERBAL GEL CONTAINING ASHWAGANDHA AND GINGER AS AN ADJUNCT TO SCALING AND ROOT PLANING IN CHRONIC PERIODONTITIS â?? IN VIVO STUDY

Dr Vishakha Padhye0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: K053- Chronic periodontitis

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K053- Chronic periodontitis
Sponsor
Dr Vishakha Padhye
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Vishakha Padhye

Eligibility Criteria

Inclusion Criteria

  • •Minimum of 20 sound teeth to be present.
  • •Age â?? 25 to 55 years of either sex.
  • •Systemically healthy patients.
  • •Patients with chronic periodontitis (AAP 1999 Classification of periodontitis) having pocket probing depth \> 4mm (preferably 4\-7mm) in more than one quadrants.
  • •Patients who have not undergone any form of dental treatment (non\-surgical or surgical periodontal therapy) in the last 6 months including oral prophylaxis.

Exclusion Criteria

  • •Patients with history of antibiotics and non\-steroidal anti\-inflammatory drug use in the past 6 months.
  • •Pregnant women and lactating mothers.
  • •Smokers and patients consuming tobacco in any other form.
  • •Immuno\-compromised patients.
  • •Patients who have history of any kind of allergy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Clinical Study To Evaluate the efficacy of polyherbal Unani formulation in Zukam (Coryza OR Common Cold)
CTRI/2023/08/056975State Unani Medical College
Recruiting
Phase 3
CLINICAL RESEARCH ON SIDDHA MEDICINE IN IYA ERAIPPU NOI(BRONCHIAL ASTHMA)
CTRI/2013/12/004253AYOTHIDOSS PANDITHAR HOSPITA125
Completed
Phase 2
Clinical Trial of Polyherbal Formulation COVI-RB01 As An Add-On Therapy With Standard of Care In Mild And Moderate Covid-19 Positive PatientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2021/10/037378Alakart Bio Pharma Pvt Ltd130
Recruiting
Phase 3
Polyherbal steam inhalation versus Nasal Fumigation in children with rhinitisHealth Condition 1: J00- Acute nasopharyngitis [common cold]
CTRI/2023/03/050876Dr Monika
Recruiting
Phase 2
Clinical Study to Evaluate the Effect of Polyherbal Unani formulations in Waram-e-lawzatayn Muzmin (Chronic Tonsillitis).
CTRI/2023/09/057524Ministry of Ayush UP